| Nome |
# |
|
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds, file e309ade0-26af-3969-e053-3a05fe0a2c94
|
234
|
|
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors, file e309ade4-58a4-3969-e053-3a05fe0a2c94
|
199
|
|
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses, file e309ade1-306b-3969-e053-3a05fe0a2c94
|
170
|
|
Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient’s characteristics, and risk factors, file e309ade1-f310-3969-e053-3a05fe0a2c94
|
155
|
|
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory, file e309ade1-b338-3969-e053-3a05fe0a2c94
|
130
|
|
Neck paraganglioma and follicular lymphoma: A case report, file e309ade2-70c9-3969-e053-3a05fe0a2c94
|
101
|
|
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids, file e309ade4-7d55-3969-e053-3a05fe0a2c94
|
85
|
|
Pathogenesis of non-functioning pituitary adenomas, file e309ade1-e8d2-3969-e053-3a05fe0a2c94
|
84
|
|
Corticotropin releasing hormone: a diagnostic marker for behavioral and reproductive disorders?, file e309ade0-246f-3969-e053-3a05fe0a2c94
|
75
|
|
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR?, file e309ade4-8d84-3969-e053-3a05fe0a2c94
|
71
|
|
A tool to predict survival in stage IV entero-pancreatic NEN, file e309ade2-c6a9-3969-e053-3a05fe0a2c94
|
64
|
|
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients, file e309ade4-813a-3969-e053-3a05fe0a2c94
|
60
|
|
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids, file e309ade0-3375-3969-e053-3a05fe0a2c94
|
57
|
|
Adrenal cavernous hemangioma: a case report, file e309ade2-0600-3969-e053-3a05fe0a2c94
|
53
|
|
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis, file e309ade1-059c-3969-e053-3a05fe0a2c94
|
50
|
|
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update, file e309ade2-b056-3969-e053-3a05fe0a2c94
|
50
|
|
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer, file e309ade0-90ac-3969-e053-3a05fe0a2c94
|
49
|
|
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH), file e309ade1-b310-3969-e053-3a05fe0a2c94
|
49
|
|
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome, file e309ade5-5850-3969-e053-3a05fe0a2c94
|
47
|
|
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience, file 766c09b2-a8ae-4fdb-90f1-849a16721718
|
41
|
|
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids, file e309ade3-ca32-3969-e053-3a05fe0a2c94
|
41
|
|
MicroRNAs in the pituitary, file e309ade4-7fd2-3969-e053-3a05fe0a2c94
|
41
|
|
Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study, file e309ade5-2d44-3969-e053-3a05fe0a2c94
|
41
|
|
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region, file e309ade0-8a6a-3969-e053-3a05fe0a2c94
|
39
|
|
Is receptor profiling useful for predicting pituitary therapy?, file e309ade1-f215-3969-e053-3a05fe0a2c94
|
39
|
|
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study, file e309ade2-160f-3969-e053-3a05fe0a2c94
|
36
|
|
Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line, file e309ade2-63df-3969-e053-3a05fe0a2c94
|
36
|
|
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours, file e309ade5-3660-3969-e053-3a05fe0a2c94
|
33
|
|
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer, file e309ade2-dd73-3969-e053-3a05fe0a2c94
|
32
|
|
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients, file e309ade3-9f29-3969-e053-3a05fe0a2c94
|
31
|
|
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame, file e309ade4-4e5f-3969-e053-3a05fe0a2c94
|
30
|
|
Open issues on G3 neuroendocrine neoplasms: Back to the future, file e309ade1-e935-3969-e053-3a05fe0a2c94
|
29
|
|
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria, file e4f85820-f75d-4a98-b524-0b5a0ef0e6e9
|
27
|
|
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2), file e309ade3-f040-3969-e053-3a05fe0a2c94
|
24
|
|
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation., file e309ade1-47f6-3969-e053-3a05fe0a2c94
|
23
|
|
Hypeprolactinemia: still an insidious diagnosis, file e309ade2-b0fd-3969-e053-3a05fe0a2c94
|
16
|
|
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement, file e309ade1-bb79-3969-e053-3a05fe0a2c94
|
14
|
|
Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients, file e309ade3-eed3-3969-e053-3a05fe0a2c94
|
14
|
|
Igf-I influences everolimus activity in medullary thyroid carcinoma, file e309ade0-8d20-3969-e053-3a05fe0a2c94
|
13
|
|
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation, file e309ade0-4690-3969-e053-3a05fe0a2c94
|
11
|
|
X-linked acrogigantism syndrome: clinical profile and therapeutic responses, file e309ade3-ca0a-3969-e053-3a05fe0a2c94
|
11
|
|
Clinico-pathological features, treatments and survival of malignant insulinomas: A multicenter study, file e309ade2-b548-3969-e053-3a05fe0a2c94
|
10
|
|
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study, file e309ade4-0136-3969-e053-3a05fe0a2c94
|
10
|
|
Should aip gene screening be recommended in family members of FIPA patients with R16H variant?, file e309ade0-37b1-3969-e053-3a05fe0a2c94
|
9
|
|
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis, file e309ade0-3a18-3969-e053-3a05fe0a2c94
|
9
|
|
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study, file e309ade5-0614-3969-e053-3a05fe0a2c94
|
9
|
|
Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling, file e309ade5-21ea-3969-e053-3a05fe0a2c94
|
9
|
|
L’acromegalia nell’anziano, file e309ade5-3361-3969-e053-3a05fe0a2c94
|
9
|
|
Radiomics in the characterization of lipid-poor adrenal adenomas at unenhanced CT: time to look beyond usual density metrics, file aa7d11e3-547b-4dc1-b529-0a2a5de01b25
|
8
|
|
Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review, file e309ade0-b2d2-3969-e053-3a05fe0a2c94
|
8
|
|
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet), file e309ade2-b0fa-3969-e053-3a05fe0a2c94
|
8
|
|
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects, file e309ade3-ae53-3969-e053-3a05fe0a2c94
|
8
|
|
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors, file e309ade5-584e-3969-e053-3a05fe0a2c94
|
8
|
|
Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4), file 5b0a6900-fc16-422c-9a31-bc23558379b7
|
7
|
|
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression., file e309ade0-26b3-3969-e053-3a05fe0a2c94
|
7
|
|
Molecular basis of pharmacological therapy in Cushing's disease., file e309ade0-45f1-3969-e053-3a05fe0a2c94
|
7
|
|
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy, file e309ade5-87ca-3969-e053-3a05fe0a2c94
|
7
|
|
Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment, file 47cf8561-099b-4c98-840a-a4015063004d
|
6
|
|
Long-term low-dose tolvaptan efficacy and safety in SIADH, file 5bb0e363-396a-4c06-8fe6-5e83b83b232c
|
6
|
|
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial, file 6328ea21-9d81-47af-8a38-f616f572d4df
|
6
|
|
Androgen influences transforming growth factor-β1 gene expression in human adrenocortical cells, file e309ade0-2d16-3969-e053-3a05fe0a2c94
|
6
|
|
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis, file e309ade0-405c-3969-e053-3a05fe0a2c94
|
6
|
|
Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype, file e309ade0-4139-3969-e053-3a05fe0a2c94
|
6
|
|
Iperprolattinemia: vecchie e nuove insidie diagnostiche, file e309ade4-e5ce-3969-e053-3a05fe0a2c94
|
6
|
|
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study, file e309ade5-0c84-3969-e053-3a05fe0a2c94
|
6
|
|
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia, file e309ade5-1dee-3969-e053-3a05fe0a2c94
|
6
|
|
Prognostic significance of laterality in lung neuroendocrine tumors, file e309ade5-4cd3-3969-e053-3a05fe0a2c94
|
6
|
|
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper, file 9cb92361-e4b3-4e32-be25-6767a4f4b667
|
5
|
|
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet), file b7f82efe-241c-431e-909d-c2d6449efbe2
|
5
|
|
Somatostatin and thyroid, file e309ade0-2d18-3969-e053-3a05fe0a2c94
|
5
|
|
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT, file e309ade0-2ee1-3969-e053-3a05fe0a2c94
|
5
|
|
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke, file e309ade0-3376-3969-e053-3a05fe0a2c94
|
5
|
|
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, file e309ade0-3770-3969-e053-3a05fe0a2c94
|
5
|
|
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas, file e309ade0-3d3a-3969-e053-3a05fe0a2c94
|
5
|
|
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression, file e309ade0-4db6-3969-e053-3a05fe0a2c94
|
5
|
|
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection, file e309ade0-9db7-3969-e053-3a05fe0a2c94
|
5
|
|
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors, file e309ade1-4e23-3969-e053-3a05fe0a2c94
|
5
|
|
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life, file e309ade4-e5cf-3969-e053-3a05fe0a2c94
|
5
|
|
Expected and paradoxical effects of obesity on cancer treatment response, file e634a1e1-19e7-44a7-86f2-e4dea5dfba58
|
5
|
|
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review, file 56f44f34-e5bb-4840-9db3-9636d2cdd7d6
|
4
|
|
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?, file 8047db6d-8ff3-4867-ad90-8e3f1d6082f5
|
4
|
|
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study., file e309ade0-26b1-3969-e053-3a05fe0a2c94
|
4
|
|
Systemic illness, file e309ade0-282d-3969-e053-3a05fe0a2c94
|
4
|
|
Real-world study of everolimus in advanced progressive neuroendocrine tumors, file e309ade0-405e-3969-e053-3a05fe0a2c94
|
4
|
|
BRAFmutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present, file e309ade0-413b-3969-e053-3a05fe0a2c94
|
4
|
|
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C , file e309ade0-b7ea-3969-e053-3a05fe0a2c94
|
4
|
|
Expected and paradoxical effects of obesity on cancer treatment response, file e309ade3-eeca-3969-e053-3a05fe0a2c94
|
4
|
|
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper, file e309ade4-f2cb-3969-e053-3a05fe0a2c94
|
4
|
|
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?, file e309ade5-5b45-3969-e053-3a05fe0a2c94
|
4
|
|
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study, file e309ade5-6e26-3969-e053-3a05fe0a2c94
|
4
|
|
Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget, file 00855b1c-f890-4855-a96d-823e326a1371
|
3
|
|
Hypeprolactinemia: still an insidious diagnosis, file 67ce3b9d-6bbf-4f21-8883-aaf459d729f1
|
3
|
|
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines., file e309ade0-26b0-3969-e053-3a05fe0a2c94
|
3
|
|
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro, file e309ade0-2ee2-3969-e053-3a05fe0a2c94
|
3
|
|
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli, file e309ade0-3372-3969-e053-3a05fe0a2c94
|
3
|
|
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model., file e309ade0-3373-3969-e053-3a05fe0a2c94
|
3
|
|
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression., file e309ade0-33b5-3969-e053-3a05fe0a2c94
|
3
|
|
Levels of p27 sensitize to dual PI3K/mTOR inhibition, file e309ade0-341b-3969-e053-3a05fe0a2c94
|
3
|
|
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro, file e309ade0-3aa7-3969-e053-3a05fe0a2c94
|
3
|
|
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects, file e309ade1-06d3-3969-e053-3a05fe0a2c94
|
3
|
| Totale |
2.732 |